Metabolite profiling of plasma and urine from rats with TNBS-induced acute colitis using UPLC-ESI-QTOF-MS-based metabonomics - A pilot study

FEBS Journal

Volumn 279, Issue 13, 2012, Pages 2322-2338

  Zhang, Xiaojun ^a   Choi, Franky F K ^a   Zhou, Yan ^b   Leung, Feung P ^a   Tan, Shun ^a   Lin, Shuhai ^a   Xu, Hongxi ^c   Jia, Wei ^d   Sung, Joseph J Y ^e   Cai, Zongwei ^a   Bian, Zhaoxiang ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b CHENGDU INSTITUTE OF BIOLOGY   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^e Chinese University of Hong Kong   (Hong Kong)

Author keywords

Experimental inflammatory bowel disease; Metabonomics; Ultra performance liquid chromatography time of flight mass spectrometry

Indexed keywords

12ALPHA HYDROXY 3 OXOCHOLADIENIC ACID; 4 (2 AMINOPHENYL) 2,4 DIOXOBUTANOIC ACID; 4 CRESOL GLUCURONIDE; 4,6 CIHYDROXYQUINOLINE; BILE ACID; CHOLESTANE 3,7,12,24,25 PENTOL; CHOLIC ACID; LYSOPHOSPHATIDYLCHOLINE; PHENYLACETYLGLYCINE; TRINITROBENZENESULFONIC ACID; TRYPTOPHAN DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; COLITIS; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; IMMUNOMODULATION; INFLAMMATION; INTESTINE MUCOSA PERMEABILITY; MALE; METABOLITE; MICROBIAL METABOLISM; NONHUMAN; PATHOPHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; RAT; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

RATTUS;

EID: 84862580679     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08612.x     Document Type: Article

References (47)

1. Blumberg RS (2009) Inflammation in the intestinal tract: pathogenesis and treatment. Dig Dis 27, 455-464.
2. Schicho R, Nazyrova A, Shaykhutdinov R, Duggan G, Vogel HJ & Storr M (2010) Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by 1H NMR spectroscopy. J Proteome Res 9, 6265-6273.
3. Clarke CJ & Haselden JN (2008) Metabolic profiling as a tool for understanding mechanisms of toxicity. Toxicol Pathol 36, 140-147.
4. Lin S, Chan W, Li J & Cai Z (2010) Liquid chromatography ? mass spectrometry for investigating the biochemical effects induced by aristolochic acid in rats: the plasma metabolome. Rapid Commun Mass Spectrom 24, 1312-1318.
5. Lin HM, Helsby NA, Rowan DD & Ferguson LR (2011) Using metabolomic analysis to understand inflammatory bowel diseases. Inflamm Bowel Dis 17, 1021-1029.
6. Mizoguchi A & Mizoguchi E (2010) Animal models of IBD: linkage to human disease. Curr Opin Pharmacol 10, 578-587.
7. Mizoguchi A & Mizoguch E (2008) Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol 43, 1-17.
8. Shi XZ, Winston JH & Sarna SK (2011) Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 300, G41-G51.
9. Martinez-Augustin O, Merlos M, Zarzuelo A, Suarez MD & de Medina FS (2008) Disturbances in metabolic, transport and structural genes in experimental colonic inflammation in the rat: a longitudinal genomic analysis. BMC Genomics 9, 490.
10. Lu X, Zhao XJ, Bai CM, Zhao CX, Lu G & Xu GM (2008) LC-MS-based metabonomics analysis. J Chromatogr B Analyt Technol Biomed Life Sci 866, 64-76.
11. Hoenicke K, Borchert O, Gruning K & Simat TJ (2002) 'Untypical aging off-flavor' in wine: synthesis of potential degradation compounds of indole-3-acetic acid and kynurenine and their evaluation as precursors of 2-aminoacetophenone. J Agric Food Chem 50, 4303-4309.
12. Wang P, Sun H, Lv H, Sun W, Yuan Y, Han Y, Wang DW, Zhang AH & Wang XJ (2010) Thyroxine and reserpine-induced changes in metabolic profiles of rat urine and the therapeutic effect of Liu Wei Di Huang Wan detected by UPLC-HDMS. J Pharm Biomed Anal 53, 631-645.
13. Lu XM, Xiong ZL, Li JJ, Zheng SN, Huo TG & Li FM (2011) Metabonomic study on 'Kidney-Yang Deficiency syndrome' and intervention effects of Rhizoma Drynariae extracts in rats using ultra performance liquid chromatography coupled with mass spectrometry. Talanta 83, 700-708.
14. Wang YL, Holmes E, Nicholson JK, Cloarec O, Chollet J, Tanner M, Singer BH & Utzinger J (2004) Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc Natl Acad Sci USA 101, 12676-12681.
15. Kuwabara M, Ushiroguchi T, Kihira K, Kuramoto T & Hoshita T (1984) Identification of bile alcohols in urine from healthy humans. J Lipid Res 25, 361-368.
16. Ran X, Liang Q, Luo G, Liu Q, Pan Y, Wang B & Pang C (2006) Simultaneous determination of geniposide, baicalin, cholic acid and hyodeoxycholic acid in rat serum for the pharmacokinetic investigations by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 842, 22-27.
17. Kajander K, Myllyluoma E, Kyronpalo S, Rasmussen M, Sipponen P, Mattila I, Seppanen-Laakso T, Vapaatalo H, Oresic M & Korpela R (2009) Elevated proinflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome. World J Gastroenterol 15, 6068-6074.
18. Gnewuch C, Liebisch G, Langmann T, Dieplinger B, Mueller T, Haltmayer M, Dieplinger H, Zahn A, Stremmel W, Rogler G et al. (2009) Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease. World J Gastroenterol 15, 3134-3141.
19. Tagesson C, Franzen L, Dahl G & Westrom B (1985) Lysophosphatidylcholine increases rat ileal permeability to macromolecules. Gut 26, 369-377.
20. Salim SY & Soderholm JD (2011) Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis 17, 362-381.
21. Allen K, Jaeschke H & Copple BL (2011) Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol 178, 175-186.
22. Lora L, Mazzon E, Martines D, Fries W, Muraca M, Martin A, DOdorico A, Naccarato R & Citi S (1997) Hepatocyte tight-junctional permeability is increased in rat experimental colitis. Gastroenterology 113, 1347-1354.
23. Shefer S, Dayal B, Tint GS, Salen G & Mosbach EH (1975) Identification of pentahydroxy bile alcohols in cerebrotendinous xanthomatosis: characterization of 5β-cholestane-3α,7α,12α,24ζ,25- pentol and 5β-cholestane-3α,7α,12α,23ζ,25-pentol. J Lipid Res 16, 280-286.
24. Mendes FD, Levy C, Enders FB, Loftus EV Jr, Angulo P & Lindor KD (2007) Abnormal hepatic biochemistries in patients with inflammatory bowel disease. Am J Gastroenterol 102, 344-350.
25. Lenicek M, Duricova D, Komarek V, Gabrysova B, Lukas M, Smerhovsky Z & Vitek L (2011) Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers. Inflamm Bowel Dis 17, 1322-1327.
26. Hofmann AF & Eckmann L (2006) How bile acids confer gut mucosal protection against bacteria. Proc Natl Acad Sci USA 103, 4333-4334.
27. Otamiri T, Sjodahl R & Tagesson C (1986) Lysophosphatidylcholine potentiates the increase in mucosal permeability after small-intestinal ischaemia. Scand J Gastroenterol 21, 1131-1136.
28. Olofsson KE, Andersson L, Nilsson J & Bjorkbacka H (2008) Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochem Biophys Res Commun 370, 348-352.
29. Chen C, Shah YM, Morimura K, Krausz KW, Miyazaki M, Richardson TA, Morgan ET, Ntambi JM, Idle JR & Gonzalez FJ (2008) Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab 7, 135-147.
30. Klapproth JMA & Sasaki M (2010) Bacterial induction of proinflammatory cytokines in inflammatory bowel disease. Inflamm Bowel Dis 16, 2173-2179.
31. Fava F & Danese S (2011) Intestinal microbiota in inflammatory bowel disease: friend or foe? World J Gastroenterol 17, 557-566.
32. Uronis JM, Arthur JC, Keku T, Fodor A, Carroll IM, Cruz ML, Appleyard CB & Jobin C (2011) Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflamm Bowel Dis 17, 289-297.
33. Bertini I, Calalbro A, De Carli V, Luchinat C, Nepi S, Porfirio B, Renzi D, Saccenti E & Tenori L (2009) The metabonomic signature of celiac disease. J Proteome Res 8, 170-177.
34. Kinross JM, Alkhamesi N, Barton RH, Silk DB, Yap IKS, Darzi AW, Holmes E & Nicholson JK (2011) Global metabolic phenotyping in an experimental laparotomy model of surgical trauma. J Proteome Res 10, 277-287.
35. Wang YL, Utzinger J, Xiao SH, Xue J, Nicholson JK, Tanner M, Singer BH & Holmes E (2006) System level metabolic effects of a Schistosoma japonicum infection in the Syrian hamster. Mol Biochem Parasitol 146, 1-9.
36. Goldstein JI, Kominsky DJ, Jacobson N, Bowers B, Regalia K, Austin GL, Yousefi M, Falta MT, Fontenot AP, Gerich ME et al. (2011) Defective leukocyte GM-CSF receptor (CD116) expression and function in inflammatory bowel disease. Gastroenterology 141, 208-216.
37. Del Angel-Meza AR, valos-Marin AJ, Ontiveros-Martinez LL, Ortiz GG, Beas-Zarate C, Chaparro-Huerta V, Torres-Mendoza BM & Bitzer-Quintero OK (2011) Protective effects of tryptophan on neuro-inflammation in rats after administering lipopolysaccharide. Biomed Pharmacother 65, 215-219.
38. Kim CJ, Kovacs-Nolan JA, Yang C, Archbold T, Fan MZ & Mine Y (2010) l-Tryptophan exhibits therapeutic function in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J Nutr Biochem 21, 468-475.
39. Shiomi Y, Nishiumi S, Ooi M, Hatano N, Shinohara M, Yoshie T, Kondo Y, Furumatsu K, Shiomi H, Kutsumi H et al. (2011) GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium. Inflamm Bowel Dis 17, 2261-2274.
40. Khan WI & Ghia JE (2010) Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol 161, 19-27.
41. Linden DR, Chen JX, Gershon MD, Sharkey KA & Mawe GM (2003) Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 285, G207-G216.
42. Griffiths WJ, Karua K, Hornshaw M, Woffendin G & Wanga Y (2007) Metabolomics and metabolite profiling: past heroes and future developments. Eur J Mass Spectrom 13, 45-50.
43. Dudley E, Yousef M, Wang Y & Griffiths WJ (2010) Targeted metabolomics and mass spectrometry. Adv Protein Chem Struct Biol 80, 45-83.
44. Messaoudi M, Desor D, Grasmuck V, Joyeux M, Langlois A & Roman FJ (1999) Behavioral evaluation of visceral pain in a rat model of colonic inflammation. NeuroReport 10, 1137-1141.
45. Friedrich AE & Gebhart GF (2000) Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat. J Pharmacol Exp Ther 292, 538-544.
46. McCafferty DM, Sharkey KA & Wallace JL (1994) Beneficial effects of local or systemic lidocaine in experimental colitis. Am J Physiol Gastrointest Liver Physiol 266, G560-G567.
47. Gue M, Bonbonne C, Fioramonti J, More J, Del Rio-Lacheze C, Comera C & Bueno L (1997) Stressinduced enhancement of colitis in rats: CRF and arginine vasopressin are not involved. Am J Physiol Gastrointest Liver Physiol 272, G84-G91.